CONDENSED STATEMENT OF CHANGES IN STOCKHOLDERS' DEFICIT - USD ($)	Class A common stock Common Stock	Class B common stock Common Stock	Additional Paid-in Capital	Accumulated Deficit	Total
Balance at the beginning at Dec. 31, 2021	$ 20	$ 288	$ 24,712	$ (31,782)	$ (6,762)
Balance at the beginning (in shares) at Dec. 31, 2021	200,000	2,875,000
Recoverable expenses paid			(24,766)		(24,766)
Costs related to issuance of EBC shares			519,415		519,415
Proceeds allocated to Public Warrants			850,000		850,000
Proceeds allocated to Rights			6,920,000		6,920,000
Warrants issuance costs			(94,647)		(94,647)
Rights issuance costs			(237,903)		(237,903)
Amount received on sale of private warrants			5,000,000		5,000,000
Accretion of Class A common stock to redemption amount			(12,390,780)		(12,390,780)
Net income (loss)				(48,269)	(48,269)
Balance at the end at Mar. 31, 2022	$ 20	$ 288	566,031	(80,051)	486,288
Balance at the end (in shares) at Mar. 31, 2022	200,000	2,875,000
Balance at the beginning at Dec. 31, 2021	$ 20	$ 288	24,712	(31,782)	(6,762)
Balance at the beginning (in shares) at Dec. 31, 2021	200,000	2,875,000
Net income (loss)					(217,269)
Balance at the end at Jun. 30, 2022	$ 20	$ 288	591,051	(249,051)	342,308
Balance at the end (in shares) at Jun. 30, 2022	200,000	2,875,000
Balance at the beginning at Dec. 31, 2021	$ 20	$ 288	24,712	(31,782)	(6,762)
Balance at the beginning (in shares) at Dec. 31, 2021	200,000	2,875,000
Balance at the end at Dec. 31, 2022	$ 20	$ 288		(152,238)	(151,930)
Balance at the end (in shares) at Dec. 31, 2022	200,000	2,875,000
Balance at the beginning at Mar. 31, 2022	$ 20	$ 288	566,031	(80,051)	486,288
Balance at the beginning (in shares) at Mar. 31, 2022	200,000	2,875,000
Proceeds from issuance of founder shares to Sponsor			25,020		25,020
Net income (loss)				(169,000)	(169,000)
Balance at the end at Jun. 30, 2022	$ 20	$ 288	591,051	(249,051)	342,308
Balance at the end (in shares) at Jun. 30, 2022	200,000	2,875,000
Balance at the beginning at Dec. 31, 2022	$ 20	$ 288		(152,238)	(151,930)
Balance at the beginning (in shares) at Dec. 31, 2022	200,000	2,875,000
Accretion of Class A common stock to redemption amount				(1,222,548)	(1,222,548)
Net income (loss)				150,388	150,388
Balance at the end at Mar. 31, 2023	$ 20	$ 288		(1,224,398)	(1,224,090)
Balance at the end (in shares) at Mar. 31, 2023	200,000	2,875,000
Balance at the beginning at Dec. 31, 2022	$ 20	$ 288		(152,238)	(151,930)
Balance at the beginning (in shares) at Dec. 31, 2022	200,000	2,875,000
Net income (loss)					(94,085)
Balance at the end at Jun. 30, 2023	$ 308	$ 0	0	(2,671,721)	(2,671,413)
Balance at the end (in shares) at Jun. 30, 2023	3,075,000	0
Balance at the beginning at Mar. 31, 2023	$ 20	$ 288		(1,224,398)	(1,224,090)
Balance at the beginning (in shares) at Mar. 31, 2023	200,000	2,875,000
Accretion of Class A common stock to redemption amount				(442,308)	(442,308)
Net income (loss)				(244,473)	(244,473)
Excise tax on stockholder redemption				(760,542)	(760,542)
Conversion of Class B ordinary shares to Class A ordinary shares	$ 288	$ (288)
Conversion of Class B ordinary shares to Class A ordinary shares (in shares)	2,875,000	(2,875,000)
Balance at the end at Jun. 30, 2023	$ 308	$ 0	$ 0	$ (2,671,721)	$ (2,671,413)
Balance at the end (in shares) at Jun. 30, 2023	3,075,000	0